Clinical Trials

Find a Trial

Trial Summary

Protocol No.EAY131-C2/MATCH
StatusOPEN TO ACCRUAL
Principal InvestigatorMiller, Kathy
ScopeNational
PhasePhase II
Age GroupAdult
TitleMATCH Treatment Subprotocol C2: Crizotinib in Patients with Tumors with MET Exon 14 Deletion
Applicable Disease SitesAny Site
Participating InstitutionsIndiana University (IU)
  • Eskenazi Hospital
  • Indiana University Hospital / IU Simon Cancer Center
  • Spring Mill Medical Center
Treatment TypeTreatment
ContactSharon Dendler, Phone: 317-274-0930
Pager:
Email: sdendler@iu.edu